Company Filing History:

14 out of 2,198

Smithkline Beecham Corporation

patents

Sunesis Pharmaceuticals, Inc.

patents

Years Active: 1998-2009

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7592357 - Compounds (2009-09-22),

2. 7560586 - Acid and ester compounds and methods of using the same (2009-07-14),

3. 7560467 - Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors (2009-07-14),

4. 7547779 - Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors (2009-06-16),

5. 7348339 - Imidazopyridine derivatives as kinase inhibitors (2008-03-25),

6. 7223760 - Substituted triazole compounds (2007-05-29),

7. 6878743 - Small molecule inhibitors of caspases (2005-04-12),

8. 6610695 - Aryloxy substituted pyrimidine imidazole compounds (2003-08-26),

9. 6599910 - Substituted triazole compounds (2003-07-29),

10. 6548520 - Substituted imidazoles having anti-cancer and cytokine inhibitory activity (2003-04-15),

11. 6514992 - Caspases and apoptosis (2003-02-04),

12. 6489339 - C3A receptor ligands (2002-12-03),

13. 6403792 - Sulfonyl isatin compounds and methods of blocking apoptosis therewith (2002-06-11),

14. 6214858 - Caspases and apoptosis (2001-04-10),

15. 5977103 - Substituted imidazole compounds (1999-11-02),

Title: The Innovative Contributions of Dennis Lee

Introduction

Dennis Lee is a prominent inventor based in San Mateo, CA. He has made significant contributions to the field of medicinal chemistry, holding a total of 17 patents. His work primarily focuses on developing novel compounds that target specific kinases, which are crucial in various biological processes.

Latest Patents

Among his latest patents, Dennis Lee has disclosed compounds that serve as novel inhibitors of Rho-kinases. Additionally, he has developed indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors. This invention relates to the derivatives, compositions, and medicaments that contain these compounds, as well as the processes for their preparation and use. These indazolo-tetrahydropyrimidine-carboxamide derivatives are particularly useful in treating diseases associated with inappropriate ROCK-1 kinase activity.

Career Highlights

Throughout his career, Dennis Lee has worked with notable companies such as SmithKline Beecham Corporation and Glaxo Group Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Dennis has collaborated with several professionals in his field, including Jerry Leroy Adams and Krista B Goodman. These partnerships have facilitated the exchange of ideas and fostered innovation in his projects.

Conclusion

Dennis Lee's innovative work in developing kinase inhibitors has the potential to impact the treatment of various diseases significantly. His contributions to medicinal chemistry and collaboration with esteemed colleagues highlight his dedication to advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.